AAAAAA
Results: 1-25/1053
Authors:
ALLEN TM
Citation: Tm. Allen, LIPOSOMAL DRUG FORMULATIONS - RATIONALE FOR DEVELOPMENT AND WHAT WE CAN EXPECT FOR THE FUTURE, Drugs, 56(5), 1998, pp. 747-756
Authors:
TAUB JW
Citation: Jw. Taub, FACTORS IN IMPROVED SURVIVAL FROM PEDIATRIC CANCER, Drugs, 56(5), 1998, pp. 757-765
Authors:
GUERRA PG
TALAJIC M
ROY D
DUBUC M
THIBAULT B
NATTEL S
Citation: Pg. Guerra et al., IS THERE A FUTURE FOR ANTIARRHYTHMIC DRUG-THERAPY, Drugs, 56(5), 1998, pp. 767-781
Authors:
VAILE JH
DAVIS P
Citation: Jh. Vaile et P. Davis, TOPICAL NSAIDS FOR MUSCULOSKELETAL CONDITIONS - A REVIEW OF THE LITERATURE, Drugs, 56(5), 1998, pp. 783-799
Authors:
DREESEN DW
HANLON CA
Citation: Dw. Dreesen et Ca. Hanlon, CURRENT RECOMMENDATIONS FOR THE PROPHYLAXIS AND TREATMENT OF RABIES, Drugs, 56(5), 1998, pp. 801-809
Authors:
DIENER HC
KAUBE HE
LIMMROTH V
Citation: Hc. Diener et al., A PRACTICAL GUIDE TO THE MANAGEMENT AND PREVENTION OF MIGRAINE, Drugs, 56(5), 1998, pp. 811-824
Authors:
FOSTER RH
WILDE MI
Citation: Rh. Foster et Mi. Wilde, DIENOGEST, Drugs, 56(5), 1998, pp. 825-833
Authors:
SPONA J
Citation: J. Spona, DIENOGEST - A VIEWPOINT, Drugs, 56(5), 1998, pp. 834-835
Authors:
KUHL H
Citation: H. Kuhl, DIENOGEST - A VIEWPOINT, Drugs, 56(5), 1998, pp. 834-834
Authors:
DOOLEY M
GOA KL
Citation: M. Dooley et Kl. Goa, FIXED COMBINATION VERAPAMIL SR TRANDOLAPRIL, Drugs, 56(5), 1998, pp. 837-844
Authors:
HANSEN JF
Citation: Jf. Hansen, FIXED COMBINATION VERAPAMIL SR TRANDOLAPRIL - A VIEWPOINT/, Drugs, 56(5), 1998, pp. 845-846
Authors:
DEQUATTRO V
Citation: V. Dequattro, FIXED COMBINATION VERAPAMIL SR TRANDOLAPRIL - A VIEWPOINT/, Drugs, 56(5), 1998, pp. 845-845
Authors:
MCCLELLAN KJ
GOA KL
Citation: Kj. Mcclellan et Kl. Goa, CANDESARTAN CILEXETIL - A REVIEW OF ITS USE IN ESSENTIAL-HYPERTENSION, Drugs, 56(5), 1998, pp. 847-869
Authors:
PETERS DC
NOBLE S
PLOSKER GL
Citation: Dc. Peters et al., TRANDOLAPRIL - AN UPDATE OF ITS PHARMACOLOGY AND THERAPEUTIC USE IN CARDIOVASCULAR DISORDERS, Drugs, 56(5), 1998, pp. 871-893
Authors:
ONRUST SV
LAMB HM
BALFOUR JAB
Citation: Sv. Onrust et al., OFLOXACIN - A REAPPRAISAL OF ITS USE IN THE MANAGEMENT OF GENITOURINARY TRACT INFECTIONS, Drugs, 56(5), 1998, pp. 895-928
Authors:
DOOLEY M
GOA KL
Citation: M. Dooley et Kl. Goa, URAPIDIL - A REAPPRAISAL OF ITS USE IN THE MANAGEMENT OF HYPERTENSION, Drugs, 56(5), 1998, pp. 929-955
Authors:
WHEELER DC
Citation: Dc. Wheeler, ARE THERE POTENTIAL NON-LIPID-LOWERING USES OF STATINS, Drugs, 56(4), 1998, pp. 517-522
Authors:
DEGROOT ANJA
VANDONGEN PWJ
VREE TB
HEKSTER YA
VANROOSMALEN J
Citation: Anja. Degroot et al., ERGOT ALKALOIDS - CURRENT STATUS AND REVIEW OF CLINICAL-PHARMACOLOGY AND THERAPEUTIC USE COMPARED WITH OTHER OXYTOCICS IN OBSTETRICS AND GYNECOLOGY, Drugs, 56(4), 1998, pp. 523-535
Authors:
CALFEE DP
HAYDEN FG
Citation: Dp. Calfee et Fg. Hayden, NEW APPROACHES TO INFLUENZA CHEMOTHERAPY - NEURAMINIDASE INHIBITORS, Drugs, 56(4), 1998, pp. 537-553
Authors:
VANOOSTEN BW
TRUYEN L
BARKHOF F
POLMAN CH
Citation: Bw. Vanoosten et al., CHOOSING DRUG-THERAPY FOR MULTIPLE-SCLEROSIS - AN UPDATE, Drugs, 56(4), 1998, pp. 555-569
Authors:
SCHAFFER A
NARANJO CA
Citation: A. Schaffer et Ca. Naranjo, RECOMMENDED DRUG-TREATMENT STRATEGIES FOR THE ALCOHOLIC PATIENT, Drugs, 56(4), 1998, pp. 571-585
Authors:
CHUTKA DS
TAKAHASHI PY
Citation: Ds. Chutka et Py. Takahashi, URINARY-INCONTINENCE IN THE ELDERLY - DRUG-TREATMENT OPTIONS, Drugs, 56(4), 1998, pp. 587-595
Authors:
SURYANARAYAN K
MARINA N
Citation: K. Suryanarayan et N. Marina, WILMS-TUMOR - OPTIMAL TREATMENT STRATEGIES, Drugs, 56(4), 1998, pp. 597-605
Authors:
JARVIS B
LAMB HM
Citation: B. Jarvis et Hm. Lamb, RIFAPENTINE, Drugs, 56(4), 1998, pp. 607-616
Authors:
CHAULET P
Citation: P. Chaulet, RIFAPENTINE - A VIEWPOINT BY CHAULET,PIERRE, Drugs, 56(4), 1998, pp. 617-617